These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11675527)

  • 1. The molecular perspective: the src oncogene.
    Goodsell DS
    Oncologist; 2001; 6(5):474-6. PubMed ID: 11675527
    [No Abstract]   [Full Text] [Related]  

  • 2. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases.
    Grimmler M; Wang Y; Mund T; Cilensek Z; Keidel EM; Waddell MB; Jäkel H; Kullmann M; Kriwacki RW; Hengst L
    Cell; 2007 Jan; 128(2):269-80. PubMed ID: 17254966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3.
    Kumar RN; Shore SK; Dhanasekaran N
    Oncogene; 2006 Feb; 25(6):899-906. PubMed ID: 16247467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenes and signal transduction.
    Wong AJ; Croce CM
    Hosp Pract (Off Ed); 1993 Jul; 28(7):128-32, 136-8, 141. PubMed ID: 8325909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.
    Ellis C; Moran M; McCormick F; Pawson T
    Nature; 1990 Jan; 343(6256):377-81. PubMed ID: 1689011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for Ras in v-Crk transformation.
    Greulich H; Hanafusa H
    Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene-mediated transformation of fetal rat colon in vitro.
    Pories S; Jaros K; Steele G; Pauley A; Summerhayes IC
    Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction.
    Kobayashi N; Kono T; Hatakeyama M; Minami Y; Miyazaki T; Perlmutter RM; Taniguchi T
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4201-5. PubMed ID: 8483935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases.
    McGlade J; Cheng A; Pelicci G; Pelicci PG; Pawson T
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8869-73. PubMed ID: 1409579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of protein-tyrosine kinases in cellular transformation.
    Varticovski L
    Sangre (Barc); 1991 Aug; 36(4):305-9. PubMed ID: 1663662
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein tyrosine kinases, with emphasis on the Src family.
    Courtneidge SA
    Semin Cancer Biol; 1994 Aug; 5(4):239-46. PubMed ID: 7528561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of Rat-1 fibroblasts with the v-src oncogene increases the tyrosine phosphorylation state and activity of the alpha subunit of Gq/G11.
    Liu WW; Mattingly RR; Garrison JC
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8258-63. PubMed ID: 8710857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene addiction.
    Weinstein IB; Joe A
    Cancer Res; 2008 May; 68(9):3077-80; discussion 3080. PubMed ID: 18451130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases.
    Kanner SB; Reynolds AB; Vines RR; Parsons JT
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3328-32. PubMed ID: 2110361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.
    Santoro MM; Penengo L; Minetto M; Orecchia S; Cilli M; Gaudino G
    Oncogene; 1998 Aug; 17(6):741-9. PubMed ID: 9715276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergent signalling in the action of integrins, neuropeptides, growth factors and oncogenes.
    Rozengurt E
    Cancer Surv; 1995; 24():81-96. PubMed ID: 7553664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation and pp60v-src autophosphorylation correlate with SHC-GRB2 complex formation in rat and chicken cells expressing host-range and kinase-active, transformation-defective alleles of v-src.
    Verderame MF; Guan JL; Woods Ignatoski KM
    Mol Biol Cell; 1995 Aug; 6(8):953-66. PubMed ID: 7579711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular effects of oncogenesis on cell-extracellular matrix adhesion (review).
    Nadav L; Katz BZ
    Int J Oncol; 2001 Aug; 19(2):237-46. PubMed ID: 11445834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.